(Q40980458)

25 September 2017

1 reference

title

A commentary on glial cell line-derived neurotrophic factor (GDNF). From a glial secreted molecule to gene therapy (English)

1 reference

25 September 2017

0 references

Bohn MC

1

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

25 September 2017

published in

Biochemical Pharmacology

1 reference

25 September 2017

volume

57

1 reference

25 September 2017

issue

2

1 reference

25 September 2017

page(s)

135-142

1 reference

Protein complexity of central nervous system cell lines

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Conditioned media derived from glial cell lines promote survival and differentiation of dopaminergic neurons in vitro: Role of mesencephalic glia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Widespread long-term gene transfer to mouse skeletal muscles and heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Regional and cell-specific expression of GDNF in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Glial cell line-derived neurotrophic factor promotes the development of adrenergic neurons in mouse neural crest cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Glial cell line-derived neurotrophic factor promotes the survival and morphologic differentiation of Purkinje cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Glial cell line-derived neurotrophic factor stimulates fiber formation and survival in cultured neurons from peripheral autonomic ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Renal and neuronal abnormalities in mice lacking GDNF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Defects in enteric innervation and kidney development in mice lacking GDNF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Renal agenesis and the absence of enteric neurons in mice lacking GDNF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Functional recovery in parkinsonian monkeys treated with GDNF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Nomenclature of GPI-linked receptors for the GDNF ligand family. GFR(alpha) Nomenclature Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Functional receptor for GDNF encoded by the c-ret proto-oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

GDNF signalling through the Ret receptor tyrosine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Neurturin, a relative of glial-cell-line-derived neurotrophic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Rat mesencephalic neurons in culture exhibit different morphological traits in the presence of media conditioned on mesencephalic or striatal astroglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Enhanced dopamine cell survival in reaggregates containing telencephalic target cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Retrograde cell changes in medial septum and diagonal band following fimbria-fornix transection: quantitative temporal analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Dexamethasone reverses adrenalectomy-induced neuronal de-differentiation in midbrain raphe-hippocampus axis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Characterization of a multicomponent receptor for GDNF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Neurturin shares receptors and signal transduction pathways with glial cell line-derived neurotrophic factor in sympathetic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Role of growth factors in degeneration and regeneration in the central nervous system; clinical experiences with NGF in Parkinson's and Alzheimer's diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Glial cell line-derived neurotrophic factor: the lateral cerebral ventricle as a site of administration for stimulation of the substantia nigra dopamine system in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Recombinant adenovirus: a gene transfer vector for study and treatment of CNS diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Dopaminergic neurons protected from degeneration by GDNF gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

The etiology of Parkinson's disease with emphasis on the MPTP story

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Expression of Escherichia coli beta-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Regulation of spinal motoneuron survival by GDNF during development and following injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Effects of GDNF on axotomized sensory and motor neurons in adult rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Long-term survival effects of GDNF on neonatal rat facial motoneurons after axotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Gene therapy -- promises, problems and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

Report to the NIH Recombinant DNA Advisory Committee on murine replication-competent retrovirus (RCR) assays (February 17, 1993).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900280-9

10.1016/S0006-2952(98)00280-9

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference